Liquid biopsies: the future of cancer early detection
S Connal, JM Cameron, A Sala, PM Brennan… - Journal of translational …, 2023 - Springer
Cancer is a worldwide pandemic. The burden it imposes grows steadily on a global scale
causing emotional, physical, and financial strains on individuals, families, and health care …
causing emotional, physical, and financial strains on individuals, families, and health care …
ESR/ERS statement paper on lung cancer screening
HU Kauczor, AM Baird, TG Blum, L Bonomo… - European …, 2020 - Springer
In Europe, lung cancer ranks third among the most common cancers, remaining the biggest
killer. Since the publication of the first European Society of Radiology and European …
killer. Since the publication of the first European Society of Radiology and European …
Liquid biopsy in prostate cancer management—Current challenges and future perspectives
Simple Summary Prostate cancer (PCa) is a widespread malignancy, representing the
second leading cause of cancer-related death in men. In the last years, liquid biopsy has …
second leading cause of cancer-related death in men. In the last years, liquid biopsy has …
An overview of precision oncology basket and umbrella trials for clinicians
JJH Park, G Hsu, EG Siden… - CA: a cancer journal …, 2020 - Wiley Online Library
With advancements in biomarkers and momentum in precision medicine, biomarker‐guided
trials such as basket trials and umbrella trials have been developed under the master …
trials such as basket trials and umbrella trials have been developed under the master …
Updates on liquid biopsy: Current trends and future perspectives for clinical application in solid tumors
Despite advances in screening and therapeutics cancer continues to be one of the major
causes of morbidity and mortality worldwide. The molecular profile of tumor is routinely …
causes of morbidity and mortality worldwide. The molecular profile of tumor is routinely …
Potential utility of liquid biopsy as a diagnostic and prognostic tool for the assessment of solid tumors: implications in the precision oncology
Liquid biopsy is a technique that utilizes circulating biomarkers in the body fluids of cancer
patients to provide information regarding the genetic landscape of the cancer. It is emerging …
patients to provide information regarding the genetic landscape of the cancer. It is emerging …
Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR
Cell-free DNA (cfDNA) has become a comprehensive biomarker in the fields of non-invasive
cancer detection and monitoring, organ transplantation, prenatal genetic testing and …
cancer detection and monitoring, organ transplantation, prenatal genetic testing and …
Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review
Patients diagnosed with epithelial ovarian cancer (OC) have a 5-year survival rate of 49%.
For early-stage disease, the 5-year survival rate is above 90%. However, advanced-stage …
For early-stage disease, the 5-year survival rate is above 90%. However, advanced-stage …
[HTML][HTML] Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect
Expression levels of biomarkers are generally unknown at initial diagnosis. The
development of theranostic probes that do not rely on biomarker availability would expand …
development of theranostic probes that do not rely on biomarker availability would expand …
Resistance to TKIs in EGFR-mutated non-small cell lung cancer: from mechanisms to new therapeutic strategies
Simple Summary Resistance to tyrosine kinase inhibitors (TKIs) of the epidermal growth
factor receptor (EGFR) in advanced mutant non-small cell lung cancer (NSCLC) constitutes …
factor receptor (EGFR) in advanced mutant non-small cell lung cancer (NSCLC) constitutes …